Femasys announces second quarter financial results for 2025

-- continued progress on regulatory approvals and global commercialization of fertility portfolio -- atlanta, aug. 08, 2025 (globe newswire) -- femasys inc. (nasdaq: femy), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the second quarter of 2025.
FEMY Ratings Summary
FEMY Quant Ranking